Jeffrey G. Clark
MS, Chief Operations Officer
Jeffrey G. Clark, is uniquely qualified to assist HyperBranch in commercializing its biodendrimer medical devices. Clark was formerly vice president of research and development for Closure Medical Corp., Raleigh, N.C., led the product development efforts from start-up to a $250 million cap publicly-traded company and has over 25 years of product development experience. In addition to being acknowledged for his role in leading Closure Medical's efforts to develop and manufacture medical-grade adhesives, now known as Dermabond® Topical Skin Adhesive, Clark also designed and developed a complete line of polypropylene specialty sutures for Sharpoint, Inc.
Dermabond® adhesive was the first cyanoacrylate medical product to receive approval from the U.S. Food and Drug Administration (FDA) for closing lacerations and incisions. Clark was named the 2001 recipient of the John W. Hyatt Award for Service to Humankind, which was sponsored by Dow Plastics and awarded by the Society of Plastics Engineers (SPE) during its 59th Annual Technical Conference (ANTEC) in Dallas. Clark received an M.S. degree in Chemistry from Drexel University.